US Stock IR Daily – October 29, 2026 (13 reports)

• Caterpillar Inc. issued a press release on October 29, 2026, reporting its financial results for the quarter ended September 30, 2026.
• This press release was filed as Exhibit 99.1 to Form 8-K and incorporated by reference into Item 2.02, “Results of Operations and Financial Condition.”
• Caterpillar Inc. also provided supplemental information regarding retail sales of machines to end users and retail sales of power systems (including reciprocating and turbine engines and locomotives) to end users and Original Equipment Manufacturers (“OEMs”).
• This supplemental information was filed as Exhibit 99.2 to Form 8-K and incorporated by reference into Item 7.01, “Regulation FD Disclosure.”

Caterpillar Inc.’s release of its financial results for the third quarter of 2026 provides investors with key information regarding the company’s recent performance. The inclusion of supplemental data on retail sales of machines and power systems to end users and OEMs is particularly noteworthy. This retail sales data may offer insights into market demand for the company’s products, which could be an important factor for investors to monitor.

• Merck & Co., Inc. filed a Form 8-K on October 29, 2026.
• This filing references a press release (Exhibit 99.1) regarding earnings for the third quarter of 2026 and certain supplemental information (Exhibit 99.2) not included in the press release, under “Item 2.02. Results of Operations and Financial Condition.”
• Exhibit 99.1 is identified as the press release issued on October 29, 2026, concerning third quarter 2026 earnings.
• Exhibit 99.2 is identified as certain supplemental information not included in the press release.

Merck has announced its third-quarter 2026 earnings. This type of disclosure typically provides key insights into the company’s financial performance and operational highlights for the period. Investors will likely analyze the detailed information provided in the referenced press release and supplemental materials to understand the company’s recent results.

• Eli Lilly and Company filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) on October 29, 2026.
• The Form 8-K relates to the company’s results of operations and financial condition for the quarter ended September 30, 2026.
• Specific financial results were announced via a press release, dated October 29, 2026, attached as Exhibit 99.1.
• This press release is furnished under Item 2.02 of the Form 8-K.

Eli Lilly has disclosed its financial results for the third quarter of 2026 through an 8-K filing. This is a standard regulatory filing that indicates the company has released its latest financial performance data to the public. Investors will likely focus on the details within the accompanying press release, which would provide insights into the company’s revenue, earnings, and product-specific performance, crucial for evaluating its operational health.

• Linde plc announced its results of operations for the quarter ended September 30, 2026, on October 29, 2026.
• This announcement was made pursuant to “ITEM 2.02 Results of Operations and Financial Condition” of Form 8-K.
• The detailed information regarding the results of operations is furnished as Exhibit 99.1, a press release, and is incorporated by reference into the Form 8-K.
• Linde plc is incorporated in Ireland and its ordinary shares are registered on the Nasdaq Stock Market under the trading symbol “LIN”.

Linde plc’s announcement of its quarterly results provides investors with essential data to assess the company’s recent operational performance. The accompanying press release is expected to contain detailed financial metrics, such as revenue, earnings, and other key indicators. This information could be valuable for analysts and investors evaluating the company’s financial health and future outlook.

• Bristol-Myers Squibb Company announced its financial results for the third quarter of 2026 on October 29, 2026.
• The company issued a press release, referred to as the “Earnings Press Release,” on its website at www.bms.com, detailing these results.
• Concurrently, a presentation, referred to as the “Bristol Myers Presentation,” was posted on the company’s website for viewing during the conference call and webcast announcing the financial results for the third quarter of 2026.
• Both the Earnings Press Release and the Bristol Myers Presentation include references to non-GAAP financial information, with reconciliations to comparable GAAP financial measures available in the Earnings Press Release.

Bristol-Myers Squibb’s release of its Q3 2026 financial results, including both a press release and a presentation, provides stakeholders with key insights into the company’s performance. The inclusion of non-GAAP financial measures, alongside their GAAP reconciliations, may suggest the company aims to offer a comprehensive view of its financial health beyond standard accounting principles. This broad disclosure could be seen as an effort to enhance transparency for investors.

• On October 28, 2026, Altria Group’s Board of Directors authorized a $1 billion expansion of the company’s existing share repurchase program.
• The expanded share repurchase program is set to expire on December 31, 2027.
• Share repurchases are dependent on marketplace conditions and other factors, and the program remains subject to the discretion of the Board.
• Altria Group issued a press release on October 29, 2026, announcing its financial results for the quarter ended September 30, 2026.

Altria Group’s decision to expand its share repurchase program by $1 billion may suggest a commitment to returning capital to shareholders. The actual execution of repurchases will depend on market conditions and Board discretion, indicating flexibility in their capital allocation strategy. This announcement, made in conjunction with quarterly financial results, could be viewed as part of a broader corporate financial strategy.

• Intercontinental Exchange, Inc. (ICE) announced its financial results for the fiscal quarter ended September 30, 2026.
• This announcement was made via a Form 8-K Current Report filed on October 29, 2026.
• A press release detailing these financial results is attached as Exhibit 99.1 to this Form 8-K.
• The company refers to non-GAAP financial information, and a description of this information along with a reconciliation to comparable GAAP financial measures is included in the attached press release and ICE’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.
• The report was signed by A. Warren Gardiner, Chief Financial Officer.

Intercontinental Exchange (ICE) has issued its quarterly earnings report, providing investors with an update on its financial performance. The availability of both a press release and the upcoming Form 10-Q means stakeholders can access detailed financial statements and non-GAAP reconciliations. This comprehensive disclosure may enable a thorough review of the company’s financial health and operational outcomes for the reported quarter.

• Amazon.com, Inc. announced its Third Quarter 2026 financial results on October 29, 2026.
• This announcement was detailed under “ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION” in the company’s Form 8-K filing.
• A press release (Exhibit 99.1) containing the financial announcement and information regarding non-GAAP financial measures (Exhibit 99.2) are incorporated by reference into the Form 8-K.
• The Form 8-K was filed with the United States Securities and Exchange Commission (SEC).

Amazon’s Third Quarter 2026 earnings announcement provides the latest update on the company’s operational performance. The included press release likely contains specific financial figures such as revenues and earnings, which are key metrics for assessing the performance of its diverse business segments, including e-commerce, AWS, and advertising. Investors may look to these details for insights into the company’s financial health and growth trajectories.

• Intel Corporation announced its financial results for the third quarter ended September 26, 2026, on October 29, 2026.
• The announcement also included forward-looking statements related to its fourth quarter of 2026.
• A press release detailing these financial results was furnished as Exhibit 99.1 to the Form 8-K.
• The press release includes non-GAAP financial measures, reconciliations to GAAP measures, and explanations of management’s use of these measures.

Intel’s release of its Q3 2026 financial results, along with Q4 2026 outlook, provides investors with key information to assess the company’s recent performance and future trajectory. The inclusion of non-GAAP financial measures and their reconciliation to GAAP figures, accompanied by management’s explanation, offers additional context for understanding the reported financial performance.

• Stryker Corporation announced its third quarter 2026 operating results on October 29, 2026.
• A press release detailing these results was issued on the same date and is attached as Exhibit 99.1 to the filing.
• This announcement was made via a Form 8-K filing with the U.S. Securities and Exchange Commission (SEC).
• Stryker Corporation’s Common Stock is listed on the New York Stock Exchange (NYSE) under the trading symbol “SYK”.

Stryker’s announcement of its Q3 2026 operating results provides key financial data for investors to assess the company’s performance. The accompanying press release likely contains details on revenues, earnings, and segmental results, which are crucial for understanding the company’s operational health and growth trajectories. Investors may use this information to evaluate Stryker’s current financial standing and consider its potential implications for future prospects.

• Gilead Sciences, Inc. announced its financial results for the quarter ended September 30, 2026, on October 29, 2026.
• The announcement was made via a Form 8-K filing with the United States Securities and Exchange Commission (SEC).
• A copy of the press release (Exhibit 99.1) regarding the financial results is filed as an exhibit to the Form 8-K.
• Gilead presented certain financial information in accordance with U.S. generally accepted accounting principles (GAAP) and also on a non-GAAP basis.
• Management believes non-GAAP information is useful for investors when considered with GAAP financial statements, as it is used internally for operating, budgeting, and financial planning purposes.

Gilead Sciences’ release of its third-quarter 2026 financial results provides key data for investors to assess the company’s recent performance. The provision of both GAAP and non-GAAP financial figures allows for a comprehensive view of the company’s profitability and operational efficiency. Investors may find it beneficial to review the full press release to understand specific revenue streams, expense controls, and any forward-looking statements or management commentary that could indicate future strategic direction.

• Mondelez International, Inc. issued a press release on October 29, 2026, announcing its earnings for the third quarter ended September 30, 2026.
• This announcement was filed with the U.S. Securities and Exchange Commission (SEC) via a Form 8-K.
• The press release (Exhibit 99.1) is furnished as an exhibit to the current report.
• The company is incorporated in Virginia and has its principal executive offices in Chicago, IL.
• Mondelez International’s Class A Common Stock is traded on The Nasdaq Global Select Market, and several of its notes are listed on The Nasdaq Stock Market LLC.

This announcement by Mondelez International provides formal disclosure regarding its third-quarter 2026 earnings, which is a key event for investors to assess the company’s financial performance. The filing of a Form 8-K indicates a significant corporate event, and investors should refer to the attached press release for detailed financial results to understand the underlying performance.

• On October 26, 2026, Meta Platforms, Inc. entered into an underwriting agreement for a Mandatory Convertible Preferred Stock offering.
• Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC acted as representatives of the underwriters.
• The Company agreed to issue and sell 250,000,000 Series A depositary shares, each representing a 1/20th interest in a share of 6.50% Series A Mandatory Convertible Preferred Stock, with a liquidation preference of $1,000.00 per share.
• The underwriters were granted an option to purchase up to an additional 37,500,000 Depositary Shares for a 30-day period to cover over-allotments.
• The Depositary Shares Offering closed on October 29, 2026.

Meta Platforms’ entry into this material definitive agreement for a Mandatory Convertible Preferred Stock offering indicates a strategic move to raise capital. This could be aimed at strengthening the company’s financial position or funding future investments and growth initiatives. The involvement of major financial institutions like Morgan Stanley and Goldman Sachs as underwriters may suggest strong market confidence in the offering.